Anzeige
Mehr »
Login
Freitag, 10.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Innocan Pharma News: Unfassbare Studie - LPT-Therapie bewahrt Patient vor dem Tod!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
Dow Jones News
82 Leser
Artikel bewerten:
(0)

EQS-News: BaWang Group Wins Libel Lawsuit against Next Magazine

EQS-News / 24/05/2016 / 15:11 UTC+8 
 
For Immediate Release 
 
BaWang International (Group) Holding Limited 
 
BaWang Wins Libel Lawsuit against Next Magazine 
* * * 
Reaffirmed Highest Product Safety and 
Assured Compliance with Health Requirements 
 
(23 May 2016, Hong Kong) Chinese herbal shampoo and personal care product brand owner BaWang International (Group) 
Holding Limited ("BaWang" or the "Company", stock code: 1338) and its indirect subsidiary, Bawang (Guangzhou) Company 
Limited, have won the libel lawsuit against Next Magazine Publishing Ltd ("Next Magazine") over an inaccurate and 
defamatory report published by Next Magazine in July 2010 which questioned BaWang's product safety and accused it as 
cancerous without proven scientific support. 
 
In the judgment made by the Honourable Lok J of the Court of First Instance, Hong Kong on 23 May 2016, the Court 
commented that "In short, the Defendant [being Next Magazine] had adopted a naïve and unprofessional approach in 
reporting the story" and that Next Magazine's report in the article was "not a product of responsible journalism." The 
Court rejected all the pleaded defences raised by Next Magazine in relation to BaWang's libel claim and found that the 
defamatory article published by Next Magazine prevented readers from knowing that in fact, BaWang's "stance of BaWang 
Shampoo Products being safe was supported by a scientific study conducted by a responsible team of scientists; published 
by a responsible regulatory agency; endorsed by the government of a scientifically advanced country." 
 
After five and a half years' lawsuit, BaWang and Bawang (Guangzhou) Company Limited were awarded general damages for 
libel in the amount of HK$2,004,652.50 and HK$1,000,000, respectively. The High Court of Hong Kong also made a costs 
order nisi that Next Magazine shall pay to Bawang and Bawang (Guangzhou) Company Limited 80% of the legal costs of 
Bawang and Bawang (Guangzhou) Company Limited in respect of the lawsuit. 
 
Mr. Chen Qiyuan, Chairman of BaWang said, "The verdict is an affirmation of BaWang's brand reputation and our high 
product safety standards. Safeguarding personal health has always been at the core of BaWang. In our five and a half 
year legal battle with Next Magazine, we have strengthened quality control in the course of production and made 
additional investments in product research and development so as to provide further assurance to consumers since the 
publication of the article. In fact, the Group's management system for production of hair care and skin care products 
have respectively been certified to be in compliance with the guidelines on cosmetics good manufacturing practice (GMP) 
separately laid down by the Centre for Food Safety & Applied Nutrition of the US Food & Drug Administration and the ISO 
22716.2007. " 
 
Mr. Chen Qiyuan also said, "We respect the press who abides by good practices, but we will not tolerate ungrounded 
derogatory reports of any kind. We believe that winning this libel lawsuit will be a step towards reclaiming our 
territory and strengthening consumer confidence in our products. Going forward, we will continue to offer safe and 
effective personal care products to consumers." 
 
During the hearing, the expert witnesses from both sides confirmed that using Bawang shampoos is safer than drinking 
water that meets the safety threshold recommended by WHO (World Health Organization). Indeed, in the Court's Judgement, 
the Judge stated that "One can also test the Defendant's suggested safety standard with the WHO's recommended safety 
level of 1,4-dioxane in drinking water. Assuming that the Plaintiffs' shampoo (being the BaWang shampoo) is to contain 
27 ppm of 1,4-dioxane (which was alleged by Next Magazine), using the Defendant's model to assess health risk, it is 
still 3 times safer using the Plaintiffs' shampoo than drinking the WHO-recommended drinking water." 
 
Additionally, the China's State Food & Drug Administration released a public circular at its official website 
respectively on 16 July 2010 and 21 July 2010 stating that BaWang's anti-hair-loss shampoo is safe for consumer use as 
the amount of dioxane is minimal and complies fully with international standards. Other evidences and testaments 
presented at the court also point to the conclusion that the accusations made by Next Magazine were untrue and not based 
on scientific findings. 
 
- End - 
 
About BaWang 
BaWang International (Group) Holding Limited is engaged in the research and development, manufacture and marketing of 
Chinese herbal shampoo and a range of personal care products. The Bawang brand has been awarded the Well-known Trademark 
of China in 2007. According to the research results of Euromonitor International, the BaWang brand has been the leading 
Chinese brand in terms of sales value in the Chinese herbal shampoo and anti-hair-loss shampoo market in the PRC between 
2007 and 2013. 
 
BaWang adopts a multi-brand strategy and operates diversified branded products including BaWang Shampoo, Royal Wind, 
Herborn and Litao. Bawang's distribution network covers 27 provinces and four municipalities in the PRC. Additionally, 
BaWang branded products are sold in Hong Kong, Singapore, Thailand, and Malaysia. 
 
Issued by Cornerstones Communications Ltd. on behalf of BaWang. For further information, please contact: 
Harriet Lau / Sharis Siu 
T: (852) 2903 9290 / 2903 9282 
E: bawang@cornerstonescom.com 
 
Document: http://n.eqs.com/c/fncls.ssp?u=LHJPHHWDBI 
Document title: BaWang Wins Libel Lawsuit against Next Magazine 
 
Key word(s): Statement 
 
24/05/2016 Dissemination of a Press Release, transmitted by EQS TodayIR - a company of EQS Group AG. 
The issuer is solely responsible for the content of this announcement. 
 
Media archive at www.todayir.com 
466061 24/05/2016 
 
 

(END) Dow Jones Newswires

May 24, 2016 03:12 ET (07:12 GMT)

Lithium vs. Palladium - Ist das die Chance des Jahrzehnts?
Sichern Sie sich den kostenlosen PDF-Report! So können Sie vom Boom der Rohstoffe profitieren.
Hier klicken
© 2016 Dow Jones News
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.